Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

C.R. Bard ( BCR) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.2%. By the end of trading, C.R. Bard rose $1.66 (1.2%) to $145.37 on average volume. Throughout the day, 720,281 shares of C.R. Bard exchanged hands as compared to its average daily volume of 686,800 shares. The stock ranged in a price between $143.50-$145.86 after having opened the day at $143.90 as compared to the previous trading day's close of $143.71. Other companies within the Health Services industry that increased today were: Arrhythmia Research Technology ( HRT), up 19.4%, Rosetta Genomics ( ROSG), up 16.4%, SunLink Health Systems ( SSY), up 14.4% and Alphatec Holdings ( ATEC), up 10.3%.

C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. C.R. Bard has a market cap of $11.1 billion and is part of the health care sector. Shares are up 7.3% year to date as of the close of trading on Friday. Currently there are 4 analysts that rate C.R. Bard a buy, 1 analyst rates it a sell, and 9 rate it a hold.

TheStreet Ratings rates C.R. Bard as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, compelling growth in net income and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

On the negative front, Baxano Surgical ( BAXS), down 10.7%, ZELTIQ Aesthetics ( ZLTQ), down 9.3%, Concord Medical Services Holdings ( CCM), down 8.9% and IMRIS ( IMRS), down 6.5% , were all laggards within the health services industry with Intuitive Surgical ( ISRG) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.